Vai al contenuto principale della pagina

Examining Emergent Biosolutions' failure to protect public health and public funds : hearing before the Select Subcommittee on the Coronavirus Crisis of the Committee on Oversight and Reform, House of Representatives, One Hundred Seventeenth Congress, first session, May 19, 2021



(Visualizza in formato marc)    (Visualizza in BIBFRAME)

Titolo: Examining Emergent Biosolutions' failure to protect public health and public funds : hearing before the Select Subcommittee on the Coronavirus Crisis of the Committee on Oversight and Reform, House of Representatives, One Hundred Seventeenth Congress, first session, May 19, 2021 Visualizza cluster
Pubblicazione: Washington : , : U.S. Government Publishing Office, , 2021
Descrizione fisica: 1 online resource (iii, 44 pages)
Disciplina: 4.OV 2:117-23
Soggetto topico: COVID-19 (Disease) - Vaccination - United States
COVID-19 Pandemic, 2020- - United States
Vaccines industry - Government policy - United States
Vaccines industry - Subsidies - United States
Vaccines - United States
COVID-19 (Disease) - Vaccination
Vaccines industry - Government policy
Vaccines industry - Subsidies
Soggetto geografico: United States
Soggetto genere / forma: Legislative hearings.
Note generali: Access ID (govinfo): CHRG-117hhrg44686.
"Serial no. 117-23."
Altri titoli varianti: Examining Emergent Biosolutions' failure to protect public health and public funds
Titolo autorizzato: Examining Emergent Biosolutions' failure to protect public health and public funds  Visualizza cluster
Formato: Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione: Inglese
Record Nr.: 9910716651603321
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui